ArticleThe American journal of bioethics : AJOB2017

A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.

Adelaide Doussau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.